The Coalition for Epidemic Preparedness Innovations has committed more than US$60 million to Moderna and other vaccine groups to speed the development of investigational vaccines against Bundibugyo ebolavirus, as health authorities respond to an outbreak affecting the Democratic Republic of the Congo and Uganda. The largest part of the package is up to US$50 million …
Goldman Sachs Boosts S&P 500 Target to 8,000 on Robust Earnings Outlook, Signaling Tailwinds for MedTech M&A and Innovation Funding Key Takeaways: Goldman Sachs raised its 2026 year-end S&P 500 target from 7,600 to 8,000, implying ~6.4% upside from the recent close of 7,519.12. The firm hiked 2026 S&P 500 EPS forecasts to $340 (24% …
Pfizer Inc. continues to strengthen its position in the global vaccines sector through targeted development programs and updates to existing offerings. As a major player in this field, the company focuses on respiratory diseases, bacterial infections, and emerging threats, aligning with broader industry trends of innovation in mRNA platforms and combination vaccines. In 2025, Pfizer …
Evonik Industries AG is expanding its capabilities in lipid nanoparticle (LNP) development and manufacturing as demand for RNA therapeutics, mRNA vaccines, and nucleic acid drug delivery continues to increase globally. The company has announced multiple investments, technology partnerships, and manufacturing expansions aimed at supporting pharmaceutical and biotechnology companies developing advanced therapies. According to the company, …